SF BUILD: Enabling full representation in science

SF BUILD：实现科学领域的全面代表性

基本信息

批准号：
10647857
负责人：
Leticia Maria MARQUEZ-MAGANA
金额：
$ 62.67万
依托单位：
SAN FRANCISCO STATE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2014
资助国家：
美国
起止时间：
2014-09-26 至 2025-06-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10647857
关键词：
Address Back Biomedical Research California Climate Collaborations Communication Communities Complex Country Cues Data Development Discrimination Educational Intervention Educational process of instructing Elements Environment Equity Ethnic Population Extramural Activities Faculty Funding Goals Health Individual Inequity Institution Leadership Literature Master of Science Mathematics Medical Mission Modeling Outcome Persons Population Postdoctoral Fellow Productivity Public Health Recording of previous events Reporting Research Research Activity Research Infrastructure Research Personnel Research Training San Francisco Scholars Program Science Scientific Inquiry Secure Signal Transduction Social Environment Social Identification Social Sciences Stereotyping Students System Testing Training Training Activity Training Programs Underrepresented Students United States National Institutes of Health Universities Vision Work career college experience graduate school health inequalities improved innovation interest learning community matriculation medical schools meetings peer coaching professor programs racial population science education skills social social science research student retention success synergism systemic barrier theories undergraduate student university student

项目摘要

Systemic barriers to engaging historically underrepresented (HU) students not only limit innovation and productivity in biomedical research, they perpetuate social inequities. To overcome these barriers to effective, equitable biomedical research that benefits all populations, the overall goal of the SF BUILD II project is to sustain promising climate transformation efforts and disseminate those found to be effective. Toward this end, promising efforts from SF BUILD I will be maintained and tested at both the primary institution, San Francisco State University (SF State), and its research partner, the University of California, San Francisco (UCSF). SF BUILD’s key innovation is its focus on changing institutions rather than individual students, to make the path to a research career more inviting. In SF BUILD I, an approach guided by the Signaling Affirmation for Equity (SAFE) model achieved progress in creating affirming and inclusive teaching and research environments. SAFE is grounded in social science theory and evidence of triggers that cause HU students to exit science, as well as social contextual cues that mitigate triggers, to improve student retention and success. Quantitative data from SF BUILD I show that growing a SAFE environment mitigates stereotype threat, promotes science efficacy, and increases science identity. As a result, participating HU students report a greater intent to pursue biomedical research careers. In SF BUILD II, inclusive and effective approaches to teaching and research training will be sustained and disseminated, and students’ meaningful engagement in the biomedical research workforce will continue to be affirmed. Systemic affirmation will take place through counter-stereotyping and microaffirmation activities in the classroom, and by engaging HU students in peer mentoring and research activities that “give back” to the communities from which they come. In addition, data on longer-term outcomes, such as graduate school matriculation and retention, will be gathered and evaluated. The SF BUILD approach capitalizes on the institutional history and mission of SF State, a predominantly undergraduate institution that has attained national prominence for preparing HU students for biomedical research careers. SF BUILD II aims to leverage SF State’s record of success to create agents of change who will build the capacity for biomedical research that benefits all populations. This goal is also a critical focus of UCSF, which—through its School of Medicine’s Differences Matter Initiative, established during SF BUILD I—aims to become the most diverse, equitable, and inclusive academic medical system in the country. The proposed work is significant because, working together, SF State and UCSF expect SF BUILD II to result in a national, large-scale model for creating collaborative, affirming, and inclusive teaching and research environments for HU undergraduates. In this way, HU students across the country will be able to successfully transition to premiere research universities and become the agents of change essential for a new, more inclusive approach to biomedical research.

吸引历来代表性不足（HU）学生的系统性障碍不仅限制了创新，生物医学研究的生产力，他们使社会不平等长期存在。为了克服这些影响有效性的障碍，公平的生物医学研究造福于所有人群，SF BUILD II 项目的总体目标是维持有希望的气候转型努力并传播那些被认为有效的努力， SF BUILD I 有希望的努力将在旧金山的主要机构进行维护和测试州立大学（SF State）及其研究合作伙伴加州大学旧金山分校（UCSF）。 BUILD 的关键创新在于它专注于改变机构而不是个别学生，以开辟通向未来的道路。在 SF BUILD I 中，一种以公平信号确认为指导的方法。（SAFE）模式在创建肯定性和包容性的教学和研究环境方面取得了进展。 SAFE 以社会科学理论和导致 HU 学生退出科学的触发因素证据为基础，如以及减轻触发因素的社会情境线索，以提高学生的保留率和成功率。来自 SF BUILD I 的数据表明，发展安全环境可以减轻刻板印象威胁，促进科学发展结果，参与的 HU 学生报告了更大的追求意愿。在 SF BUILD II 中，生物医学研究职业具有包容性和有效的教学和研究方法。培训将持续和传播，学生有意义地参与生物医学研究劳动力将继续得到肯定，通过反成见和系统性的肯定。课堂上的微肯定活动，以及让 HU 学生参与同伴指导和研究 “回馈”他们所在社区的活动此外，有关长期成果的数据，例如研究生院的入学和保留，将被收集和评估 SF BUILD 方法。充分利用旧金山州立大学的机构历史和使命，该大学主要是本科院校，在为 HU 学生准备生物医学研究职业方面享有盛誉。利用旧金山州立大学的成功记录来创造变革推动者，培养生物医学能力这一目标也是加州大学旧金山分校的一个重点关注点，该学院通过其学院。医学差异问题倡议 (Medicine’s Differences Matter Initiative) 在 SF BUILD I 期间建立，旨在成为最多元化、拟议的工作意义重大，因为：旧金山州立大学和加州大学旧金山分校共同努力，期望 SF BUILD II 能够形成一个全国性的大规模模型，用于创建通过这种方式，为 HU 本科生提供协作、肯定和包容的教学和研究环境。全国各地的 HU 学生将能够成功过渡到一流的研究型大学成为变革的推动者，对于新的、更具包容性的生物医学研究方法至关重要。

项目成果

期刊论文数量（13）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Improving biology faculty diversity through a co-hiring policy and faculty agents of change.

DOI：
10.1371/journal.pone.0285602
发表时间：
2023
期刊：
PLOS ONE
影响因子：
3.7
作者：
Harris, Marissa;Rosser, Sue;Goldman, Michael;Marquez-Magana, Leticia;Rohlfs, Rori V. V.
通讯作者：
Rohlfs, Rori V. V.

The Influence of Affirming Kindness and Community on Broadening Participation in STEM Career Pathways.

DOI：
10.1111/sipr.12046
发表时间：
2018-01
期刊：
Social issues and policy review
影响因子：
9.4
作者：
Estrada M;Eroy-Reveles A;Matsui J
通讯作者：
Matsui J

Ancestry-Dependent Enrichment of Deleterious Homozygotes in Runs of Homozygosity.

纯合性运行中有害纯合子的祖先依赖性富集。

DOI：
10.1016/j.ajhg.2019.08.011
发表时间：
2019
期刊：
American journal of human genetics
影响因子：
9.8
作者：
Szpiech,ZacharyA;Mak,AngelCY;White,MarquittaJ;Hu,Donglei;Eng,Celeste;Burchard,EstebanG;Hernandez,RyanD
通讯作者：
Hernandez,RyanD

Genome-wide association study of asthma exacerbations despite inhaled corticosteroid use.

DOI：
10.1183/13993003.03388-2020
发表时间：
2021-05
期刊：
The European respiratory journal
影响因子：
0
作者：
Hernandez-Pacheco N;Vijverberg SJ;Herrera-Luis E;Li J;Sio YY;Granell R;Corrales A;Maroteau C;Lethem R;Perez-Garcia J;Farzan N;Repnik K;Gorenjak M;Soares P;Karimi L;Schieck M;Pérez-Méndez L;Berce V;Tavendale R;Eng C;Sardon O;Kull I;Mukhopadhyay S;Pirmohamed M;Verhamme KMC;Burchard EG;Kabesch M;Hawcutt DB;Melén E;Potočnik U;Chew FT;Tantisira KG;Turner S;Palmer CN;Flores C;Pino-Yanes M;Maitland-van der Zee AH;PiCA and SysPharmPedia consortia
通讯作者：
PiCA and SysPharmPedia consortia

Role of Sex on the Genetic Susceptibility to Childhood Asthma in Latinos and African Americans.

DOI：
10.3390/jpm11111140
发表时间：
2021-11-03
期刊：
Journal of personalized medicine
影响因子：
0
作者：
Espuela-Ortiz A;Herrera-Luis E;Lorenzo-Díaz F;Hu D;Eng C;Villar J;Rodriguez-Santana JR;Burchard EG;Pino-Yanes M
通讯作者：
Pino-Yanes M